Active Biotech AB - Company Profile
Powered by 
All the sales intelligence you need on Active Biotech AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Active Biotech AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Active Biotech AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Active Biotech AB patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2022281056A1 | Application | A plurality of tasquinimod particles and use thereof | A61K31/4704; A61K9/14; A61P35/00; A61P35/02 | November 30, 2023 |
| EP4277628A1 | Application | Tasquinimod oder pharmazeutisch unbedenkliches salz davon zur verwendung bei der behandlung des myelodysplastischen syndroms | A61K31/4704; A61K38/1709; A61P35/02; C07D215/54 | November 22, 2023 |
| AU2022248724A1 | Application | Laquinimod formulation for ocular use | A61K31/4704; A61K47/10; A61K47/183; A61K47/186; A61K47/32; A61K47/38; A61K47/44; A61K9/0048; A61K9/08; A61K9/107; A61P27/02; A61P27/06 | November 02, 2023 |
| IL305997A | Application | Laquinimod formulation for ocular use | A61K31/4704; A61K47/10; A61K47/183; A61K47/186; A61K47/32; A61K47/38; A61K47/44; A61K9/0048; A61K9/08; A61K9/107; A61P27/02; A61P27/06 | November 01, 2023 |
| KR1020230133317A | Application | 골수이형성 증후군의 치료에 이용하기 위한 타스퀴니모드또는 이의 약제학적으로 허용가능한 염 | A61K31/4704; A61K38/1709; A61P35/02; C07D215/54 | September 19, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer